Operating Room Integration Market to Expand at a CAGR of 11.0% Through 2028: Grand View Research Inc.

 Operating Room Integration Market Growth & Trends

The global operating room integration market size is anticipated to reach USD 3.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.0% from 2021 to 2028. Increasing redevelopment projects and the adoption of advanced healthcare IT solutions in hospitals is a major factor boosting market growth. Operating Rooms (OR) are increasingly becoming complex and congested due to the requirement of devices during surgeries such as surgical lights, operating tables, and surgical displays. Integrated Operating Rooms (I-ORs) is becoming a solution for this complexity in ORs.

Though digitization was now high on the agendas of most companies, the COVID-19 pandemic speeded up the paradigm shift towards digitization in 2020. Besides, the trend towards digital ORs was also quickened up by the pandemic. Thus, the COVID-19 crisis created new opportunities to innovate and new ways to create value in the evolving healthcare world. For instance, in March 2021, Olympus has introduced EASYSUITE, a next-generation OR integration solution, in the EMEA area. EASYSUITE features video management and routing, medical content management, procedure recording, and virtual collaboration. As a result, with the introduction of EASYSUITE, the company promoted digitalization in surgery and boosted its position in the EMEA territory.

The modern operating room provides consolidated data and offers access to audio and video and controls for all surgical devices at the central command station, allowing the surgeon to achieve various tasks efficiently without the prerequisite to move near the OR. Other advantages of OR integration are it minimizes manpower, maximizes OR efficiency, takes less surgical time procedure, and manages patient surgical records.

Most of the Minimally Invasive Surgeries (MIS) procedures such as TAVR, and EVAR, laparoscopic procedures are performed in hybrid integrated OR. Surging patient preference for MIS is boosting the market growth. MIS includes robotic surgery; laparoscopic surgeries that have a wide range of applications in the medical sector.

In addition, hospitals have shifted their preference towards advanced MIS procedures for diagnosing chronic diseases. The preference is due to the benefits that this procedure provides such as lower postoperative complication rates along with reduced hospital stay, less painful and offers fast recovery time. It also provides a high accuracy rate as compared to traditional open surgery. The aforementioned factors are anticipated to boost the demand for I-ORs over the forecast period.

The competitors operating in the market are focusing on other strategies such as mergers and acquisitions, collaborative agreements to mark their presence in the market. For instance, In January 2020, Brainlab declared its acquisition of Vision Tree Software. Vision tree Optimal Care (VTOC) platform, which provides EHR, research, and registry platform. The acquisition will provide an opportunity to capture data by point-of-care electronic forms and use them in efficient workflows. The strategies like these implemented by the leader in this vertical are further propelling the market growth.

Request a free sample copy or view report summary: Operating Room Integration Market Report

Operating Room Integration Market Report Highlights

• OR integrated services are expected to witness the fastest growth rate in coming years owing to the growing demand from ambulatory surgical centersand hospitals
• The documentation management systems segment dominated the market in 2020 owing to the associated benefits such as data management with minimal errors
• Demand for fully integrated solutions to automated surgical workflows is growing in accordance with the requirements to access all the necessary information on a single platform. This helps in expediting the surgical procedure and eliminates the need for various devices arranged all over in the operating room
• The orthopedic surgery segment is anticipated to show a lucrative CAGR owing to its growing demand. There is an increase in the number of cases of orthopedic conditions, including osteoarthritis, osteoporosis, rheumatoid arthritis, and ligamentous knee injuries
• North America dominated the market as of 2020, which is attributable to supportive government initiatives promoting the adoption of surgical automation, telemedicine, and other advanced technologies to support the use of integrated solutions in operating rooms
• Market players are involved in extensive research for the development of cost-efficient and technologically advanced OR integration solutions. Subsequently, the introduction of such solutions is expected to provide the market with lucrative growth opportunities

Access Press Release@ https://www.grandviewresearch.com/press-release/global-operating-room-integration-market

Operating Room Integration Market Segmentation

Grand View Research has segmented the global operating room integration market based on component, device type, application, end-use, and region:

Operating Room Integration Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services

Operating Room Integration Device Type Outlook (Revenue, USD Million, 2016 - 2028)

• Audio Video Management System Forceps
• Display System
• Documentation Recording System

Operating Room Integration Application Outlook (Revenue, USD Million, 2016 - 2028)

• General Surgery 
• Orthopedic Surgery
• Neurosurgery
• Others 

Operating Room Integration End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Operating Room Integration Regional Outlook (Revenue, USD Million, 2016 – 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • UAE

List of Key Players of Operating Room Integration Market

• Stryker
• Brainlab AG
• Barco
• Dragerwerk AG & Co. KGaA
• Steris
• KARL STORZ SE & CO. KG
• Getinge AB
• Olympus
• Care Syntax
• Trilux Medical GmbH& Co.KG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Workflow Solutions Market Valuation to Reach USD 19.25 Billion by the end of 2028: Grand View Research Inc.

 Clinical Workflow Solutions Market Growth & Trends

The global clinical workflow solutions market size is expected to reach USD 19.25 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.4% from 2021 to 2028. An increased volume of patient health information due to the rising prevalence of chronic conditions and the high demand for better quality care by patients is expected to fuel the adoption of workflow software and services in healthcare settings. Rising awareness amongst the caregivers and patients pertinent to the benefits of integrated solutions and interest in reliable technology for efficient decision-making is anticipated to fuel the adoption of workflow solutions.

The interoperability and compatibility of the systems with different platforms due to their robust technology have enhanced the growth prospects for the market. Collaborative efforts by software developers along with researchers to make healthcare information available to users are projected to contribute to the lucrative growth over the forecast period. Furthermore, strategic initiatives intended by the industry participants for developing end-to-end solutions are expected to boost the competition in the market.

The COVID-19 pandemic presented numerous challenges such as financial challenges to the healthcare organizations. The pandemic continues to focus on how interconnected the world’s social, economic, and environmental challenges are. The market players are increasingly focusing on bringing innovation and new ways to safeguard the health and safety of their employees, meeting critical customer requirements, and guaranteeing business continuity. For instance, in July 2020, Hillromproclaimed a new commercial partnership with Aivato to enable voice-permitted clinical workflows. Thus, it allows hands-free communication for both patients and staff.

Moreover, improvements in healthcare IT have offered an ever-expanding array of options like advanced broadband networks, remote patient monitoring, and EHRs. This, in turn, created substantial opportunities for clinical workflow solution vendors. With the help of these integration solutions, healthcare organizations can advance clinical workflow and significantly improve their care delivery system. For example, integration of EHR and telehealth automates data entry. With this, there is no requirement to enter the same information twice, which diminishes duplicate data entries and administrative tasks and upsurges efficiency in the workplace.

Market participants are engaged in collaborative agreements with hospitals and healthcare groups to implement clinical workflow management systems and EHR solutions. Moreover, focus on developing an integrated software solution to avoid wrong medication and improve the quality of care is expected to fuel the adoption of workflow solutions in the coming years.

Request a free sample copy or view report summary: Clinical Workflow Solutions Market Report

Clinical Workflow Solutions Market Report Highlights

• By type, data integration solutions held the largest share in 2020 owing to their rapid adoption by hospitals and healthcare facilities. Besides, as the healthcare industry is moving toward digitization, electronic medical record systems are becoming more and more popular, thus supporting the segment growth
• The care collaboration solutions type segment is likely to witness lucrative growth over the forecast period due to the rapid adoption of these solutions by caregivers. Integration with EHR provides a complete overview of the patient’s medical condition, thereby helping to decide a course of action for treatment
• In terms of end use, the hospitals segment captured the largest revenue share in 2020. This can be attributed to supportive government policies, a rise in awareness, and an increase in the number of training programs for the implementation of the technology
• North America dominated the market in 2020 owing to the presence of major players and technologically advanced healthcare infrastructure
• Asia Pacific is projected to witness lucrative growth in the coming years owing to the supportive government initiatives to adopt eHealthsolutions by hospitals

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-workflow-solution-market

Clinical Workflow Solutions Market Segmentation

Grand View Research has segmented the global clinical workflow solutions market on the basis of type, end use, and region:

Clinical Workflow Solutions Type Outlook (Revenue, USD Million, 2016 - 2028)

• Data Integration Solutions
  • EMR Integration Solutions
  • Medical Image Integration Solutions
• Real-time Communication Solutions
  • Nurse Call Alert Systems
  • Unified Communication Solutions
• Workflow Automation Solutions
  • Patient Flow Management Solutions
  • Nursing & Staff Scheduling Solutions
• Care Collaboration Solutions
  • Medication Administration Solutions
  • Perinatal Care Management Solutions
  • Rounding Solutions
  • Other Care Collaboration Solutions (Specimen Collection Solutions and Blood Products Administration Solutions)
• Enterprise Reporting & Analytics Solutions

Clinical Workflow Solutions End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Long-term Care Facilities
• Ambulatory Care Centers

Clinical Workflow Solutions Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Workflow Solutions Market

• Allscripts Healthcare Solutions, Inc.
• Cerner Corporation
• NXGN Management, LLC
• McKesson Corporation
• Koninklijke Philips N.V.
• Hill-Rom Services Inc.
• Cisco
• General Electric
• Stanly Healthcare
• Vocera Communications
• ASCOM
• athenahealth, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antiviral Drugs Market Size Projected to Rise Lucratively during 2021 to 2028: Grand View Research Inc.

 Antiviral Drugs Market Growth & Trends

The global antiviral drugs market size is expected to reach USD 60.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of (-0.6%) from 2021 to 2028. This is owing to the loss of patent protection of drugs and the high R&D investment required for developing antiviral drugs. However, the rising prevalence of viral infections and the presence of a potential pipeline for the treatment of HIV infection are expected to fuel the growth over the forecast period.

The increasing prevalence of influenza with other complications such as viral pneumonia, obesity, and the rising geriatric population drives the market growth. Moreover, pneumonia is one of the major causes of death in children worldwide. According to the WHO, Pneumonia causes 808,694 children’s deaths in 2017, accounting for 15.0% of all deaths of children under 5 years old. It is most prevalent in South Asia and the sub-Saharan African region.

The awareness of viral infections, their prevention, and treatment are high in most of the regions. For instance, according to CDC, in 2019, the vaccination rate against influenza was 49% in the U.S., which prevented around 4.4 million influenza infections and around 3,500 deaths in the country. Moreover, the increase in vaccination rate against hepatitis and herpes is affecting the market growth over the forecast period.

Increasing collaboration between government bodies and key players is anticipated to fuel the growth of R&D activities in the development of novel antiviral drugs. For instance, in June 2021, Merck & Co., Inc. entered into a procurement agreement with the U.S. government for molnupiravir, an investigational antiviral for COVID-19 treatment. According to the agreement, the company will receive USD 1.2 billion to supply around 1.7 million courses of the drug to the U.S. government, if molnupiravir receives emergency use authorization or approval by the U.S. FDA.

Companies are adopting strategies such as product development and collaboration to increase their share in the market. For instance, in April 2021, Janssen Pharmaceuticals, Inc. and Cidara Therapeutics, Inc. collaborated to develop Cidara’s Cloudbreak antiviral conjugates for the prevention and treatment of influenza. Moreover, in October 2020, F. Hoffmann-La Roche Ltd and Atea Pharmaceuticals, Inc. also collaborated to develop, manufacture, and market AT-527 for the treatment of COVID-19. AT-527 acts as an RNA polymerase inhibitor and stops viral replication.

Favorable initiatives undertaken by government bodies to prevent and treat viral infections are expected to support the management of viral infections. For instance, the U.K. government has launched an antiviral task force to investigate treatments for SARS-CoV-2 infection in home-based settings. It will help prevent the infection and limit the effect of new variants of the SARS-CoV-2 virus. Moreover, the U.S. government is investing more than USD 3 billion to fasten the development of antiviral drugs against COVID-19 and other viral infections.

The upsurge in COVID-19 cases and strong pipeline products is expected to positively impact market growth. According to the WHO, as of 1^st September 2021, a total of 217.56 million confirmed cases of COVID-19, including 4.52 million deaths reported. For instance, in May 2021, based on Favipiravir formula antiviral drug BALflue was launched by BAL Pharma, it is used for the treatment of patients with mild to moderate Covid-19 infection as well as used in the treatment of 53 types of influenza viruses. Overall, the outbreak of the COVID-19 pandemic is estimated to propel the market growth, however, it has adversely affected the consumption of antiviral medicines from other applications owing to disruption in the supply chain and limited access to healthcare services during the complete lockdown.

Request a free sample copy or view report summary: Antiviral Drugs Market Report

Antiviral Drugs Market Report Highlights

• An increase in the COVID-19 case is expected to drive market growth in the next 2 to 4 years
• The reverse transcriptase inhibitors segment dominated the market due to the high efficacy of drugs and growing prevalence of diseases like HIV and hepatitis B, globally
• The HIV segment dominated the market in 2020 and is projected to maintain its dominance over the forecast period, owing to the commercialization of pipeline products over the forecast period
• North America dominated the market in 2020 and Asia Pacific is expected to exhibit fastest growth during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antiviral-drugs-market

Antiviral Drugs Market Segmentation

Grand View Research has segmented the global antiviral drugs market on the basis of drug class, type, application, and region:

Antiviral Drug Class Outlook (Revenue, USD Million, 2017 - 2028)

• DNA Polymerase Inhibitors
• Reverse Transcriptase Inhibitors
• Protease Inhibitors
• Neuraminidase Inhibitors
• Others

Antiviral Drugs Type Outlook (Revenue, USD Million, 2017 - 2028)

• Branded
• Generics

Antiviral Drugs Application Outlook (Revenue, USD Million, 2017 - 2028)

• HIV
• Hepatitis
• Herpes
• Influenza
• Others

Antiviral Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Antiviral Drugs Market

• Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• AbbVie
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Cipla Inc.
• Aurobindo Pharma
• Reddy’s Laboratories Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Restorative Dentistry Market Poised for Robust Value CAGR of Over 8.6% Through 2028

 

Restorative Dentistry Market Growth & Trends

The global restorative dentistry market size is expected to reach USD 30.02 billion by 2028, according to the new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.6% from 2021 to 2028. The growth of the market is attributed to the improved quality of services provided in dentistry for the large patient pool. The transmission of COVID-19 by the generation of aerosol produced by dental handpieces is possible. To avoid this, the correct clinical protocols must be followed during the COVID-19 pandemic.

The COVID-19 pandemic adversely affected the dental market in 2020. According to the WHO guidelines, viral infection mainly spreads through the eyes, nose, and mouth that makes it difficult for the dentist to operate on patients during such times. The routine cleaning, orthodontic procedures, preventive therapies, and oral examinations that do not involve pain management were postponed during the COVID-19 pandemic, thus negatively impacting the market.

Technological advancements such as guided tissue regeneration with CAM/CAD software solutions, computer-aided implant dentistry, and digital radiography have improved the accuracy of restorations. The new equipment and composite materials have compelled the patients for treatment and resulted in better health outcomes and higher satisfaction, along with the timeliness of dental treatment. Thus, advanced technology is anticipated to boost the growth of the market.

The lack of reimbursement may affect market growth. The reimbursement policies for dental structure do not include restorative dentistry. Patients must bear out-of-pocket expenditure that is included with dental procedures, thus patients mainly ignore and delay their dental treatments due to high expenses. Dental procedures such as composite bonding, implants, and cosmetic contouring require high skilled lab technicians and professionals. Thus, dental procedures are very costly in many countries. This factor may hamper market growth.

Request a free sample copy or view report summary: Restorative Dentistry Market Report

Restorative Dentistry Market Report Highlights

• By product, the restorative materials segment held the largest market share in 2020 due to the rising disposable income and the growing awareness regarding the benefits of good oral health
• Based on the end use, the dental hospitals and clinics segment captured the largest market share in 2020 as the number of standalone clinics is expected to grow due to more dentists in emerging areas
• Europe led the market in 2020 and is expected to maintain its lead over the forecast period owing to technological advancements, an increase in patients opting for cosmetic procedures, and rising oral disease burden in the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-restorative-dentistry-market

Restorative Dentistry Market Segmentation

Grand View Research has segmented the global restorative dentistry market on the basis of product, end-use, and region:

Restorative Dentistry Product Outlook (Revenue, USD Billion, 2016 - 2028)

• Restorative Materials
  • Direct Restorative Materials
    • Amalgam
    • Composites
    • Glass Ionomer
    • Other Direct Restorative Materials
  • Indirect Restorative Materials
    • All-ceramic
    • Metal Ceramic
    • Metal Alloys
    • Other Indirect Restorative Materials
  • Biomaterials
  • Bonding Agents/ Adhesives
  • Impression Materials
• Implants
• Prosthetics
• Restorative Equipment
  • CAD/CAM Systems
  • Handpieces
  • Rotary Instruments
  • Light Curing Equipment
  • Casting Equipment
  • Mixing Equipment
  • Articulating Equipment
  • Other Equipment

Restorative Dentistry End-use Outlook (Revenue, USD Billion, 2016 - 2028)

• Dental Hospitals and Clinics
• Dental Labs
• Research and Teaching Institutes

Restorative Dentistry Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Restorative Dentistry Market

• 3M Company
• Dentsply Sirona
• Danaher Corporation
• Septodont Holding
• Ivoclar Vivadent AG
• COLTENE Holding Ag
• GC Corporation
• Mitsui Chemicals, Inc.
• Institut Straumann AG
• Zimmer Biomet Holdings, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Chair Market Get Facts About Business Strategies 2021 to 2028: Grand View Research Inc.

 Dental Chair Market Growth & Trends

The global dental chair market size is expected to reach USD 693.6 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.1% from 2021 to 2028. Rising focus on oral care and aesthetic has increased the adoption of dental procedures, which is anticipated to boost the market growth. In addition, advanced dentistry is time-saving that has various benefits such as less chair time, less invasive procedures, shorter and fewer appointments, and patient satisfaction. This is expected to propel the growth of the market. On the other hand, according to the Oral Health Group, in March 2020, during the COVID-19 pandemic, the health and regulators authorities declared all dental offices to stop seeing patients immediately, resulting in unprecedented revenue drops across the sector.

The COVID-19 has negatively impacted the market for dental chairs. According to the WHO guidelines, the infection mainly spreads through the eyes, nose, and mouth, and at such times, the dental practitioners have been unable to open and operate from their clinics. Travel restrictions on medical tourism in countries, such as India and China, have led to a negative impact on the market.

Chairs that are easy to access for disabled and elderly people give comfort to the patient and make the procedure have a frontal view of the face that helps dentists to operate easily. Advancement in the technology of dentistry such as digital radiography, 3-D imaging, printing and scanning, laser dentistry, practice management software, and CAD/CAM and chair-side milling has shifted the dentistry to next level of advanced diagnosis and treatment. Thus, this factor is anticipated to boost the growth of the market.

Request a free sample copy or view report summary: Dental Chair Market Report

Dental Chair Market Report Highlights

• Based on product, the powered dental chairs segment accounted for the largest volume share in 2020 due to the advancement in technology
• In terms of type, the ceiling-mounted design segment dominated the market in 2020 as it offers assistance in performing multiple surgeries along with movable lights
• By application, the examination segment held the largest volume share in 2020 owing to the increasing prevalence of dental diseases and awareness regarding oral health
• Asia Pacific is anticipated to grow significantly over the forecast period due to the growing medical tourism in emerging countries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dental-chair-market

Dental Chair Market Segmentation

Grand View Research has segmented the global dental chair market on the basis of product, type, application, and region:

Dental Chair Product Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2028)

• Powered Dental Chairs
• Non-powered Dental Chairs

Dental Chair Type Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2028)

• Ceiling Mounted Design
• Mobile Independent Design
• Dental Chair Mounted Design

Dental Chair Application Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2028)

• Examination
• Surgery
• Orthodontics
• Others

Dental Chair Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Dental Chair Market

• Austin Dental Equipment Company (A-Dec, Inc.)
• Midmar
• Craftsmaster Contour Equipment, Inc.
• XO CARE A/S
• Sirona
• Henry Schein, Inc.
• Danaher Corporation
• PLANMECA OY
• Patterson Dental Supply, Inc.
• Straumann

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Liquid Biopsy Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

 Liquid Biopsy Market Growth & Trends

The global liquid biopsy market size is expected to reach USD 19.35 billion by 2028, registering a CAGR of 13.5% during the forecast period, according to a new report by Grand View Research, Inc. It is a revolutionary technique that has created various opportunities that were previously unexplored.

It aids in the detection and isolation of circulating tumor DNA, exosomes, and circulating tumor cells and is a source of proteomics and genomics information in cancer patients. Rapid development in digital Polymerase Chain Reaction (PCR) and NGS-based technology has improved the accuracy of liquid biopsy. It can be performed repeatedly for disease monitoring and is anticipated to help overcome the limitations of tissue biopsies.

As liquid biopsies are the most promising novel techniques for cancer care, established as well as emerging companies have increased their R&D to develop novel liquid biopsy solutions. For instance, in September 2021, AnchorDx Medical Co., Ltd.; a China-based developer of early cancer detection and oncology screening solutions developed a diagnostic model for early breast cancer detection. The model is based on the methylation patterns of cfDNA.

Request a free sample copy or view report summary: Liquid Biopsy Market Report

Liquid Biopsy Market Report Highlights

• The Multi-gene Parallel Analysis (NGS) technology segment held the largest revenue share of the global market in 2020
• This can be attributed to rapid enhancements in NGS technology. With this technology, liquid biopsies are anticipated to gain considerable importance in cancer-related studies and research
• On the basis of sample type, blood sample-based tests dominated the market in 2020
• Blood samples can readily be taken at a more frequent interval, thus increasing the adoption rate
• Circulating Nucleic Acids are the most commonly used biomarker for liquid biopsy tests
• The factors, such as the constantly evolving pipeline of ctDNA-based liquid biopsy tests, an increasing number of commercialized products, and the potential of ctRNA in determining molecular profile have contributed to the dominance of this segment
• North America is expected to be the largest revenue-generating region by 2028 owing to a high incidence of cancer, rapid technological advancements, and the presence of key players in the region
• Key players are focused on business expansion through product launches, mergers & acquisitions, agreements, partnerships, and other growth strategies
• For instance, in June 2021, Biocept, Inc. collaborated with Quest Diagnostics to provide advanced NGS-based liquid biopsy testing for lung cancer patients

Access Press Release@ https://www.grandviewresearch.com/press-release/liquid-biopsy-market

Liquid Biopsy Market Segmentation

Grand View Research has segmented the global liquid biopsy market on the basis of sample type, biomarker, technology, and region:

Liquid Biopsy Sample Type Outlook (Revenue, USD Million, 2017 - 2028)

• Blood Sample Based
• Others

Liquid Biopsy Biomarker Outlook (Revenue, USD Million, 2017 - 2028)

• Circulating Nucleic Acids
• CTC
• Exosomes/Microvesicles
• Circulating Proteins

Liquid Biopsy Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Multi-gene-parallel Analysis (NGS)
• Single Gene Analysis (PCR Microarrays)

Liquid Biopsy Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

List of Key Players of Liquid Biopsy Market

• QIAGEN
• Myriad Genetics, Inc.
• BIOCEPT, Inc.
• Guardant Health, Inc.
• Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Angle plc
• Oncimmune
• Thermo Fisher Scientific, Inc.
• Lucence health Inc.
• Freenome holdings, Inc.
• EPIGENOMICS AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Body Contouring Devices Market Trends And Forecast 2021-2028: Grand View Research Inc.

 Body Contouring Devices Market Growth & Trends

The global body contouring devices market size is expected to reach USD 9.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.6% from 2021 to 2028. Body Contouring is an aesthetic procedure that helps in eliminating unwanted fat, shape and define areas of the body, and can tighten the skin where the treatment is being carried out. Factors like rising demand and acceptance for body contouring procedures, increasing beauty-conscious consumer pool, and advancement in minimally invasive body contouring treatments that is safe, effective, and offer lower complication risks are expected to propel market growth.

According to the American Society of Plastic Surgeons, 15.7 million cosmetic minimally-invasive procedures were performed in 2019, out of which 386,557 were non-invasive fat reduction procedures. This can be attributed to the rapidly increasing desire among the youth population to look flawless. Moreover, growing social media influence through promotions and beauty campaigns has led to an increase in the demand for body contouring treatments.

Invasive body contouring treatments like Liposuction were among the top five cosmetic surgical procedures being carried out in the U.S in 2020. Liposuction is a great alternative for reducing larger deposits of excess fat (5 liters of fat from this procedure), and it also provides dramatic and long-lasting results. Technological advancement and an extensive range of devices in the body contouring market that offers high patient satisfaction and visible results are expected to boost market growth.

In the light of COVID-19, the market was hampered as the footfall of patient appointments for surgical treatments was temporarily suspended. However since the government in many countries has allowed resuming elective surgical procedures, clinics have also resumed aesthetic procedures by adhering to strict Covid-19 protocols. Moreover, many aesthetic professionals believe that there will be a surge in demand for beauty and aesthetic treatment post-Covid-19 crisis and this is expected to propel market growth

Request a free sample copy or view report summary: Body Contouring Devices Market Report

Body Contouring Devices Market Report Highlights

• The segment of non-invasive body contouring treatments dominated the market in 2020, as it provides instant results, causes little to no pain, has a low recovery period, and high patient satisfaction
• The other segment of end used reciprocated the largest share in 2020. As factors like the increasing prevalence of obesity and high aesthetic consciousness are leading to an increased demand for fat reduction procedures
• North America dominated the global market in 2020, owing to high personal disposable income, high expenditure on healthcare, a large pool of certified professionals, an increased prevalence of obesity among the population, strong aesthetic infrastructure
• Asia Pacific is expected to reciprocate the highest CAGR over the forecast period due to the rising prevalence of obesity and the presence of key players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-body-contouring-devices-procedures-market

Body Contouring Devices Market Segmentation

Grand View Research has segmented the global body contouring devices market on the basis of type, application, and region:

Body Contouring Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

• Noninvasive and Minimally Invasive Devices
• Invasive Devices

Body Contouring Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Nonsurgical Skin Resurfacing
• Nonsurgical Skin Tightening
• Cellulite Treatment
• Liposuction
• Others

Body Contouring Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Body Contouring Devices Market

• Cynosure, Inc.
• Alma Lasers
• Allergan Plc
• MerzPharmaGmbh
• Candela Medical Ltd.
• Solta Medical Bausch Health Companies, Inc.
• Lutronic Corporation
• InMode Ltd.
• Fotona
• Sofwave Medical Ltd.
• Sciton Inc.
• Lumenis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market For Healthcare Cyber Security to Witness Tremendous Growth and Expansion by 2028

 Healthcare Cyber Security Market Growth & Trends

The global healthcare cyber security market size is expected to reach USD 39.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 18.0% from 2021 to 2028. An increasing number of cyberattacks in the healthcare industry, raise in threats, and concern for privacy and security are contributing to the growth of healthcare cyber security. The increase in cases of cyberattacks and data breaches globally has raised the concern thereby, increasing demand for cyber security. For instance, the Secretary of U.S. Department of Health and Human Services (HHS) Breach of Unsecured Protected Health Information listed 592 breaches of unsecured protected health data affecting more than 500 individuals within the last two years that are currently under investigation by the Office for Civil Rights. 306 of the breaches were submitted in 2020.

The increasing digitalization and penetration of the internet are increasing the chances of the cyberattack healthcare industry is the most vulnerable to cyberattacks due to the valuable data it owns. Various cyberattacks are witnessed by the healthcare sector. For instance, the recent cyberattacks on Ireland's Department of Health and Health Service Executive (HSE) were witnessed. The HSE was impacted by a human-operated ‘Conti’ ransomware attack which severely disabled several HSE systems and necessitated the shutdown of the majority of its other systems. Also, the Federal Bureau of Investigation (FBI) and Cybersecurity and Infrastructure Security Agency (CISA) issued a warning for escalating these attacks. THE FBI and CISA observed Conti ransomware is used in more than 400 cyberattacks in the U.S. and worldwide.

Furthermore, technological advancements in the development of different products to control cyberattacks and safeguard the data are expected to boost market growth. For instance, in February 2020, GE Healthcare introduced a new cyber security solution known as Skeye for hospitals for detecting, analyzing, and responding to security threats in real-time.

Request a free sample copy or view report summary: Healthcare Cyber Security Market Report

Healthcare Cyber Security Market Report Highlights

• The market is expected to grow well by 2028 owing to increasing cyberattacks in the healthcare industry and the growing adoption of advanced cyber security solutions
• The antivirus and antimalware solution segment dominated the market in 2020 due to its extensive use increasing malware attacks
• The malware type segment dominated the market in 2020 due to its awareness and preferences of the hackers
• The hospitals end-use segment dominated the market in 2020 as they are most vulnerable to cyberattacks, which led to the extensive adoption of cyber security

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-cyber-security-market

Healthcare Cyber Security Market Segmentation

Grand View Research, Inc. has segmented the global healthcare cyber security market report on the basis of type of solutions, type of threats, end-use, and region:

Healthcare Cyber Security Types of Solution Outlook (Revenue, USD Million, 2016 - 2028)

• Identity and Access Management
• Risk and Compliance Management
• Antivirus and Antimalware
• DDoS Mitigation
• Security Information and Event Management
• Intrusion Detection System/ Intrusion Prevention System
• Others

Healthcare Cyber Security Type of Threat Outlook (Revenue, USD Million, 2016 - 2028)

• Malware
• DDoS
• Advanced Persistent Threat
• Spyware
• Lost or Stolen Devices
• Others

Healthcare Cyber Security End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharma & Chemicals
• Medical Devices
• Health Insurance
• Hospitals
• Others

Healthcare Cyber Security Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • Italy
  • France
• Asia Pacific
  • Japan
  • China
  • South Korea
  • Australia
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Israel

List of Key Players of Healthcare Cyber Security Market

• Cisco
• IBM
• FireEye
• Symantec
• Trend Micro
• MacAfee
• Intel
• Kaspersky
• Lockheed Martin
• Northrop Grumman

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

C-reactive Protein Testing Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 C-reactive Protein Testing Market & Trends

The global C-reactive protein testing market size is expected to reach USD 5.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 0.3% from 2021 to 2028. The market growth can be attributed to substantial research activities to explore the applications of C-reactive protein (CRP) testing coupled with the presence of private as well as public agencies which grant funds to expedite the research proceedings in this arena.

A rise in the number of strategic deals and developments coupled with the increase in investments for R&D of C-reactive protein testing is expected to drive the market significantly. The ongoing COVID-19 pandemic has affected the CRP testing market to a great extent. As CRP is considered to be the determining biomarker for the severity of infection/inflammation, the market is witnessing increased demand for CRP testing services and products. Major operating companies such as Abbott offer supportive tools for CRP testing for SARS-CoV-2 infection.

The development of novel technologies to analyze CRP concentration is a high-impact rendering driver for market growth. The emergence and advances in nano-technological tools are expected to provide an attractive perspective in designing portable bioanalytical assays with high specificity and sensitivity, faster response time, and multiplexing capabilities for on-site accurate disease diagnosis, and monitoring. Plasmonic nanoparticles (PNPs) is a tool that can be used for bio-sensing applications owing to their versatile optical properties.

Request a free sample copy or view report summary: C-reactive Protein Testing Market Report

C-reactive Protein Testing Market Report Highlights

• The immunoturbidimetric assay generated the largest revenue share amongst all the assay types in 2020 owing to the development and launch of the highly sensitive, automated, and less expensive immunoturbidimetric assay with a broad measuring range for the levels of C-reactive protein in samples
• hs-CRP was the highest revenue-generating detection range segment in 2020 as it features a broad detection range as compared to conventional CRP
• Cardiovascular diseases are the most common application of c-reactive protein testing and is anticipated to dominate the market throughout the analysis period
• This is because of the high adoption rate of c-reactive protein tests to detect inflammation in arteries and thus patients at high risk for heart attack, stroke, peripheral arterial diseases, and other cardiovascular disorders
• The hospitals segment registered the market share in 2020 owing to the rising penetration of CRP testing in hospitals, especially after the COVID-19 pandemic, and thereby increase in the testing rate
• North America accounted for the largest market share in 2020. This can be attributed to various factors such as well-established healthcare infrastructure, supportive government policies, and high R&D investments in the region
• In addition, the rising incidence of chronic heart diseases and cancers is also one of the major factors responsible for market growth
• The Asia Pacific is projected to grow at the fastest pace. The COVID-19 pandemic was originated in China. Being the potential biomarker for determining the severity of the infection and the rapidly increasing number of COVID-19 cases in Asian countries, the demand for CRP testing is expected to increase in the near future
• According to an article published in June 2021, doctors are recommending CRP testing for the COVID-19 patients with critical conditions who are in hospital care. This is expected to increase the demand, in turn, driving the market
• These companies are involved in their business expansion through the launch of novel products and expand their market presence through agreements, partnerships, and other initiatives

Access Press Release@ https://www.grandviewresearch.com/press-release/c-reactive-protein-crp-testing-market

C-reactive Protein Testing Market Segmentation

Grand View Research has segmented the global C-reactive protein testing market on the basis of assay type, detection range, disease area, end-use, and region:

C-reactive Protein Testing Assay Type Outlook (Revenue, USD Million, 2017 - 2028)

• Immunoturbidimetric Assay
• ELISA
  • Clinical
  • Non-clinical
• Chemiluminescence Immunoassay
• Others

C-reactive Protein Testing Detection Range Outlook (Revenue, USD Million, 2017 - 2028)

• hs-CRP
• Conventional CRP
• cCRP

C-reactive Protein Testing Disease Area Outlook (Revenue, USD Million, 2017 - 2028)

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

C-reactive Protein Testing End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Clinics
  • By Entity
    • Physician Offices
    • Small Clinics
    • Others
  • By Settings
    • Urban Setting
    • Rural Setting
  • Hospitals
    • Urban Setting
    • Rural Setting
  • Laboratories
    • Urban Setting
    • Rural Setting
  • Assisted Living Healthcare Facilities
    • Urban Setting
    • Rural Setting
  • Home
  • Others

C-reactive Protein Testing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

 List of Key Players of C-reactive Protein Testing Market

• Thermo Fisher Scientific, inc.
• Hoffmann-La Roche Ltd
• Danaher
• Quest Diagnostics
• Siemens Healthineers AG
• Abbott
• Merck KGaAA
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech, Inc
• HORIBA, Ltd
• Randox Laboratories Ltd
• BODITECH MED, INC.
• Aidian

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Information System Market Will Be Worth USD 539.3 Billion by 2028: Grand View Research Inc.

 Healthcare Information System Market Growth & Trends

The global healthcare information system market size is expected to reach USD 539.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.9% from 2021 to 2028. The demand for information systems is expected to continuously increase over the forecast period, mainly due to the increasing prevalence of chronic diseases and the aging population. The growing demand-supply gap in the healthcare industry has led to an increase in the use of IT, thereby boosting the adoption of cloud computing in healthcare companies. The rising demand for cloud-based information systems in healthcare organizations is expected to boost the market growth over the forecast period. The increase in the adoption of information systems in hospitals for improving operational efficiency, growing awareness regarding advanced services, and the growing requirements for reducing healthcare costs are among the key factors contributing to the market growth.

The COVID-19 pandemic has positively impacted the market growth and transformed the fortunes of healthcare companies. It has immensely impacted hospital systems, diagnostic centers, research centers, and the economy. The pandemic created a rapid demand for the usage of advanced technology-based healthcare information systems such as electronic health records (EHRs), electronic medical records, real-time healthcare systems, and prescription management software solutions.

Furthermore, IT companies and healthcare institutions are collaborating at a greater level to focus on the development of high-utility services and products to improve the delivery of personalized care, streamline data storage, and make effective use of data analytics. For instance, some of the advanced services implemented in hospitals using various technology platforms include real-time locating services, self-service kiosks, report monitoring tools, portal technology, and pharmacogenomics, which are helping improve the overall hospital administration and patient experience.

Request a free sample copy or view report summary: Healthcare Information System Market Report

Healthcare Information System Market Report Highlights

• The market growth is attributed to an increase in the number of government initiatives being undertaken across the globe to develop and deploy healthcare information systems
• The revenue cycle management application segment dominated the market in 2020 due to the rising need for optimization of organizational workflow in the healthcare sector
• The cloud-based deployment segment is expected to register the highest CAGR over the forecast period owing to the growing adoption of cloud-based technology
• The services component segment dominated the market in 2020 owing to the high demand for experts in IT and communication services and the growing adoption of technologically advanced products and IT infrastructure in healthcare organizations
• North America dominated the market in 2020 owing to the high demand for technologically advanced solutions and services in healthcare systems in the U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-information-system-market

Healthcare Information System Market Segmentation

Grand View Research, Inc. has segmented the global healthcare information system market report on the basis of application, deployment, component, end-use, and region:

Healthcare Information System Application Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital Information System
  • Electronic Health Record
  • Electronic Medical Record
  • Real-time Healthcare
  • Patient Engagement Solution
  • Population Health Management
• Pharmacy Information Systems
  • Prescription Management
  • Automated Dispensing Systems
  • Inventory Management
  • Others
• Laboratory Information Systems
• Revenue Cycle Management
• Medical Imaging Information System
  • Radiology Information Systems
  • Monitoring Analysis Software
  • Picture Archiving and Communication Systems

Healthcare Information System Deployment Outlook (Revenue, USD Million, 2016 - 2028)

• Web-based
• On-premises
• Cloud-based

Healthcare Information System Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software and Systems
• Services

Healthcare Information System End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Diagnostic Centers
• Academic and Research Institutes

Healthcare Information System Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Healthcare Information System Market

• McKesson Corporation
• Cerner Corporation
• athenahealth, Inc.
• Allscripts
• Medidata Solutions Inc.
• Agfa Gevaert NV
• GE Healthcare
• Siemens Healthineers
• Epic Systems Corporation
• NextGen Healthcare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.